Focused on solving unmet needs in ophthalmology

Addressing significant unmet medical needs for better topical therapy
image/svg+xml TABLEAU_OCULIS modif 2020-04-20T17:26:10+02:00 2020-04-20T17:26:10+02:00 2020-04-20T17:26:10+02:00 Adobe Illustrator 24.0 (Macintosh) 256 100 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAZAEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9U4q7FXYq7FXYqtmjWWJ 4mqFdSpI60IpirFH/LXR/qZsob3ULa0MZiMEVxROLKitsyt19OvhVj7UlxIpExeR7SMljqWoSMYn hV3mUsqyKVJU8Kgjl19h71FpUp/y9sJ4pIptT1F0kf1HUzrxPxF+PHhx4gnYU2x4kUpN+Wumlyw1 XU1ryNEuFWjMGXltGDyo9K4eJaZai8EValuIA5Mak07k5FKTaz5VtdVvY7uS8vLWRI/S42s3pKwq SC1ASSpbbfCCqU3X5bWksUoi1fUUndCkUskwl9Pk/OqgqDWtO/bDxIpVg/LyzjcTHVdRNxRQ8qzB agSGXiPhJC8jSlenvvjxLS7/AJV7YH1+ep6jIZkEas86sYgJY5h6R4VU8oV+jBxLTn/L3T2d5BqW orK6lDKJl58TH6dORQnbqK9DvjxLTcH5f6fAZPS1LUU9UyMwWcL8cpDc/hQfEpUUJ+muNppG+WvK 0GhCYRXU1z6yRIfWIPERFyAlAKL+82XsMSbVV1XQbPW9PtYbl5YhARNDJCwR1kMLxBgSDuolJHvT EFUtk8gWTGIrqupxvCpUOtzUsSa8n5K3Ij3xtFLLj8utOml9X9J6jG4JKFJ0HDknA8P3e23398PE tJ5aadHp2nSwJNNOlGblO/qNuu+9O5FfmcilVvbGHUNKuLCcsILyB4JSho3CVCjUJB3ocVSBfy80 2IKlrqOo2tujs8dvDOBGvKQScRVGNPhp16e++HiRScaRolvpakRTTTs0ccTSXDiRyIuXElqAk/Hv iSlFxn/Sph7J/HArH9Q8gaVeX01+l1eWd3cGQzS2soQsJVRCu6sKD0hT3w2il9v5GsIlYSX99c8p UmBnmElGjLkBRxoAfV327D3q2lPbs0iX/jJF/wAnFwKlWr+UdM1PUF1GWSeC+SNYY7iCTgyohc0A oRuZTWowgqg4PINjErK+p6jcKyCNlnuA60BjIPHhSv7kfecbRScafplvpenW1hbs7QwNRGkILHkx bcgKO/hgSlPmLzzZaHqEVpcWk8gcx85kC0CyCQ8lWvJ+PomtBtUYQLRaCvPzR0a1tppntLslAfST 0wObcGcL12NUKnrTbxw8K2q3v5l6HYT3cV5BcxfVJngZwiMHKBySlGqR+7322qK0O2PCtpz5e8xW GvWb3lisghR/TPqrwJPFXqNzUUcb/wAMBFJV9cvpNP0XUL+JPVltLaadI/5mijLhfpIwwFkBhklw xJ7g+RtT8x67qd5JeX19PPcSklmZ2oPZRWigdgM3sccQKAeOnqMkjZJT608sXU9paXDa2QLlVYxx 8pZE58Pi4K/IovqUYjcMCKHrlJygEinOhppEA8fP8d6he+U54ba7uZtWiaS2eZFj5rI0no1IAaN5 FDELUiu1Rua5KOUWBTXPSGiTLlf2fFjiXd2gok0ijwViB+By7hDhDJIciV31++/5aZf+Db+uPCO5 Piz7yjdDvr061p4NxIQbmEEF2/34PfITiOEtuDLLxI7nmGY635W1HU9f1q+TWrezibWL2AwTzMjo iTMWl4j9hV65jwyCMQKvYOfPTznKUuOhxS6+aGl8g6rBHA0/mG1VpxH8CzSPweSlEcqKKfi7/PD4 8f5qPyMwN5/ehrTyZq1y9yo122jW1ZFkkknZQwcIS6d2RVflXwGE5oj+FjHSTN+vl5un8la7EGVN XhlnVCzQpOSeYUOEBrQk1I8Kqw7YjNHuU6PJ/P396Ik8g6vHcW8P+ILWQXMcsqyRTu6qsUixryI/ n58h7A16YPHjX0p/JZLA4+d9W1/L7WGVmXzDaEIQGP1hwKGR46gnqF4VanQY+PH+an8jk/n/AGsR v31Gyvri0e7d2t5GjLpIzI3E05KQdweozIiARdOvySnGRjZ281D6/ff8tEv/AAbf1yXCO5h4s+8u +v33/LTL/wAG39ceEdy+LPvLvr99/wAtMv8Awbf1x4R3L4s+8u+v33/LRL/wbf1x4R3L4s+8u+v3 3/LRL/wbf1x4R3L4s+8u+v33/LTL/wAG39ceEdy+LPvLvr99/wAtMv8Awbf1x4R3L4s+8u+v33/L RL/wbf1x4R3L4s+8u+v33/LTL/wbf1x4R3L4s+8u+v33/LTL/wAG39ceEdy+LPvLJfy1vLx/Pmhq 88jKbpKqzsQevico1MR4ZczQZJHNGyfwH1XmleqdiqnN+x/rjFVTFXYqtkjjkjaORQ8bgq6MAQQe oIOKtoiIioihUUBVVRQADYAAYq5gpUhgCpFGB6U98VfNvmbTvybTWbkWepX6RczWO0iSaBWruI3c oSvh1+ebfHLNW4DzefHpOI1I/DklX1H8qf8Aq6at/wBIsP8A1UyfFl7g08Gl/nS+SHms/wAtQ9It T1Yp/wAwcB/E3Cfqwg5e4fNhKOm6GfyCpBZflgUPrapqwau3+iQLt9Ez/rxJy9wZRhpuspfJU+o/ lT/1dNW/6RYf+qmDiy9wTwaX+dL5IvSbL8rxqtkYdT1VphPF6atbQhS3MUBIfpXIzllo7BsxQ03G KlK7CK82Wf5aN5p1lrzUtUjuzfXJuEjt4WRZDM3MKS4JUN0wY5ZeEUByZZ4abxJXKV2Uq+o/lT/1 dNW/6RYf+qmT4svcGng0v86Xyd9R/Kn/AKumrf8ASLD/ANVMeLL3BeDS/wA6Xyd9R/Kn/q6at/0i w/8AVTHiy9wXg0v86Xyd9R/Kn/q6at/0iw/9VMeLL3BeDS/zpfJ31H8qf+rpq3/SLD/1Ux4svcF4 NL/Ol8nfUfyp/wCrpq3/AEiw/wDVTHiy9wXg0v8AOl8nLY/lXxHLVNW5U3pbQ0r/AMjMeLL3BeDS /wA6Xyd9R/Kn/q6at/0iw/8AVTHiy9wXg0v86Xyd9R/Kn/q6at/0iw/9VMeLL3BeDS/zpfJzWP5V 8Tx1TVuVNq20NK/8jMeLL3BeDS/zpfJwsfyqpvqmrV7/AOjQ/wDVTHiy9wXg0v8AOl8nfUfyp/6u mrf9IsP/AFUx4svcF4NL/Ol8nfUfyp/6umrf9IsP/VTHiy9wXg0v86XyaFj+VfI11TVuO1P9Ghr7 /t48WXuC8Gl/nS+Tf1H8qf8Aq6at/wBIsP8A1Ux4svcF4NL/ADpfJ31H8qf+rpq3/SLD/wBVMeLL 3BeDS/zpfJPfI1p+Xaeb9IbTNQ1KW+FynoRz28SRk135MrkjbKs5ycBsCnJ0cNOMo4TLifReap6F 2Kqc37H+uMVVMVdirsVdiqB120ub3RNQs7V/Tubm2mhgk6cXkjKq30E5KBoglhkiTEgc6fHl7ZXd jdy2l5C8FzAxSWGQFWVh2IOb8EEWHipwMTR2IZHZeZvLsNraRPpEZmhVBNM0cMvPiY+SFXUEiTgz Fi3IcuIIAymWOVndzoanEAAY/YPL7/mp3PmHy5JaXUUOjrHLO05jlb02MYkrwKlVSlDx2AotPhG5 xGOVjdEtRiMSBDc33MZy9wHYqjtC/wCO3p//ADEw/wDJwZGf0ltwf3kfeGZ615p0PTfMPmC1u/L1 vqN0NXvJUvJWAI/fuAhUo3JfYnMaGKRiCJVsHPyamEJyBgJHiO/x9yX6f5y8qW9WuPKkF25PM8pg q8/3Z2UQ/ZrD9n/KYd8mcMz/ABNcdXiH+THz/Yum86+WCHNv5UtoXZKKxkWUBqSfFxeEjrNWn+So 7Y+DL+ck6zH0xj8fBZeecPKlxFJGvlSCESen8ccwDrwcs/EiIU5q3H269qYjDMfxIlq8R/yY/Hwa v/OPlm5sbiCHytb21xMkqpcJKPgaQ8lYL6X+6yTx4kbUHQbscMgfqWerxmJAxgX+O5V/xv5WadZH 8o2nH1JGkjSXirI44qorG3EqKEEbcqmlDQDwZfzin87j/wBTj+Pggl806AbFraXy9CZDE0SXEbqj gsjKHP7pqurNyB+g1oCJeFK74mH5rGRXAPx8EVF5z8rRoVHlS3duUzq0koajSSF06RCqxqSvHodu lMBwy/nMxrMQ/wAmPx8GtQ84+V7qJ1i8q21s7NAQ8cv7MMgaRaemP71V4njTx8ascMh/EierxkbY wOX45dWpPOHlZqU8sRKAa0Ese5PIVJ9Dur9B8NQCANwXwZfzvx80/nMX+pj7P1LB5s8sLHYonlmE G1dGndplZplSExENyhI+IkOdiOQ6YfClv6mP5rHt+7G327V3fFWTzn5VVGU+VIGJZ2jcyrVfU3I/ uaMF/Zr0Hvvg8GX85l+cxf6mPx8EDr3mnSNRsngs9AttOmkZSbiMgkKGZiFARKcqqK+C07nJQxEH eVtWfUwnGhAR/HuY3lzhuxV2KuxVk/5Zf8p9of8AzFJ/HKNT/dlzez/7+P46PrHNI9a7FVOb9j/X GKqmKuxV2KuxVD6hfQWFhc31waQWkTzzEdQkalm/AYYizTGUhEEnkHzbrP5z+adRv5LiOGzghO0U LW0UxVB0BeVWYn/OmbeOkiB1eaydq5CbAACKt/M/5mXEUMsVpYlLjj6Ja2sV5NJx4JRgDzcSKVXq QQQKZE48Q6n7W6Oo1JAIEd/chZ9e/MOZZ7lrSx4W4k9VvqenNtACXK8kYsKIxBWtQDTocIhj5Wfm WuWbUmzQ28o9Etg/M7zRCnBBY0rX/eC0X/iMajLDpo+fzaY9o5R3fIKn/K1fNfhY/wDSFbf80YPy sPP5p/lPL5fJF6T+Z/mibVbKFxZcJJ4kallbA0ZwDQhNsjPTRAPP5tmLtHJKYBrcjonOv+bfP58x azHp1lBPZ21/cwRyCxgk2SZkXk5QknbcnK4YsfCLO9d7fk1Oo45cIsCRHLzQbeZ/zSUEtpcI4hy3 +4+22EYq5PwfsjrkvDxd/wBrHx9V/NHyCT/8rV81+Fj/ANIVt/zRln5WHn83G/lPL5fJ3/K1fNfh Y/8ASFbf80Y/lYefzX+U8vl8nf8AK1fNfhY/9IVt/wA0Y/lYefzX+U8vl8nf8rV81+Fj/wBIVt/z Rj+Vh5/Nf5Ty+Xyd/wArV81+Fj/0hW3/ADRj+Vh5/Nf5Ty+Xycv5p+alUKBZUAoP9Ctv+aMfysPP 5r/KeXy+Tv8Alavmvwsf+kK2/wCaMfysPP5r/KeXy+Tv+Vq+a/Cx/wCkK2/5ox/Kw8/mv8p5fL5O b80/NTKVIsqEUP8AoVt/zRj+Vh5/Nf5Ty+XycPzU81gUpZbf8uVt/wA0Y/lYefzX+U8vl8nf8rV8 1+Fj/wBIVt/zRj+Vh5/Nf5Ty+Xyd/wArV81+Fj/0hW3/ADRj+Vh5/Nf5Ty+XyaH5p+agxallU0r/ AKFbdv8AYY/lYefzX+U8vl8m/wDlavmvwsf+kK2/5ox/Kw8/mv8AKeXy+T6N0HTtMu9D067nsbZp 7i2hllYQxirvGGY0C+JzUzkQSLemxgGINdEXLpWkwhJY7KCORZI+LpEisD6iioIFchxFnwjuTDAl 2Kqc1Pgr/OMVVMVdirsVdiqjeWkF5Zz2lwvKC5jeKVelUdSrD7jhBo2iQBFF83+YPyd1PTdTltoN V014AaxfWLqOCbgfs843pQ/LbNtDVgjkXmsvZcoyoSjXmW4/KnnWOGKBde0wwwgLHE1/bsoApT4W qNuCgewA6YDlh3H5NkdPnAAE40PNSuNI88Ilxay6/p0sV0H+sK+pWjcxLu1fUfl1/swiUOfCfkWM secAgzjv/SCWwflvq8ycl1HSRvSn6Qtj/wARZhlh1AHQ/Joj2fM/xR+ap/yrDWf+rlpP/SfB/XB+ Zj3H5J/k2f8AOj80XpP5a6vDqtlK2o6UyxzxOVW+hLEK4OwB3ORnqAQdj8mzF2fMTBuOxHVOtf8A LPnBPMOsmw1ywtbS41C8nW3a/ijI9dnRuaE7N6blSDlcMkOEWDyHRvyafMJy4ZxAMiefeg5NA8/y SGRvMencyHBYahbj+8AD9PHiMPHj/mn5IOLUfz4/P9iTf8qw1n/q5aT/ANJ8H9ct/Mx7j8nF/k2f 86Pzd/yrDWf+rlpP/SfB/XH8zHuPyX+TZ/zo/N3/ACrDWf8Aq5aT/wBJ8H9cfzMe4/Jf5Nn/ADo/ N3/KsNZ/6uWk/wDSfB/XH8zHuPyX+TZ/zo/N3/KsNZ/6uWk/9J8H9cfzMe4/Jf5Nn/Oj83L+WOsF Qf0lpIqK0N/CD+vH8zHuPyX+TZ/zo/N3/KsNZ/6uWk/9J8H9cfzMe4/Jf5Nn/Oj83f8AKsNZ/wCr lpP/AEnwf1x/Mx7j8l/k2f8AOj83N+WOsBSf0lpJoK0F/CT+vH8zHuPyX+TZ/wA6PzcPyx1kiv6S 0nf/AJf4P64/mY9x+S/ybP8AnR+bv+VYaz/1ctJ/6T4P64/mY9x+S/ybP+dH5u/5VhrP/Vy0n/pP g/rj+Zj3H5L/ACbP+dH5tD8stYLFf0lpO1N/r8NN/px/Mx7j8l/k2f8AOj82/wDlWGs/9XLSf+k+ D+uP5mPcfkv8mz/nR+b6Z8vwNb6DpsDMrNDawRsyEMpKxqKqw2I8DmnmbJenxiogeSJuj+6Xav7y P/k4uRZq2KuxVTm/Y/1xiqpirsVdirsVQOuz3kGiahPYryvYraZ7VetZVjJQf8FTJQAJFsMhIia5 0+OZ55p5nnndpZpWLySOSzMzGpJJ3JJzoAKeJlIk2WTWejeTZLS0km1GT15An1mISJHxDenzYc0o ChZ1CFvi48uQByiU52dnPhgwmIJlv7/2fY79BeUvqWoSjVQ88H1g2sSyAc+FfSA5xJzr8Nfs8qmn 2aM+JOxsvgYeEni3F1v8ujFcvde7FUdoX/Hb0/8A5iYf+TgyM/pLbg/vI+8My17QfK93r3mC71DX BZXv6V1BRZCPkxVJHZG5VAHJ6Lv/AAzGhkmIgAWKDsMmDFKcjKVHilt8Uut/LfkuR5BJr7Ii3Dwx uY0HKNXjQSUL7BubOP8AJXxyZyT/AJrXHTYD/H18mKXCRpPIkbc41ZlR/EA0B28cvHJwJgAkBTws XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX2L5W/5RjSP+YK3/5NLmgyfUfe9ti+ge5G3dfSWn+/Iv8A k4uQbFbFXYqpzfsf64xVdWX+Vf8Agj/TFXVl/lX/AII/0xV1Zf5V/wCCP9MVdWX+Vf8Agj/TFXVl /lX/AII/0xV5d5j8n/k/Nqs0t60dtdsxM8drNIE5nrVUVlU+IFMy4Z8oGzr8uiwSlZG6V/4J/JT/ AJapP+R0/wD1Tyf5jMw/k/T932lRm8kfkrz21C5T/JR5SPvMDYRqMrE9n6fzXw+SfyVCb3sz79Xl mU/cIVwHUZkjs/T/AIJX/wCCfyU/5apP+R0//VPH8xmT/J+n7vtKvZeTfybjvIJLe5kM6SI0IM03 2wwK9Y/HAc+Wkx0OnBBA395Vta8oflFcazfz6hcut/LcSvdqJZgBMzkyAAR0+1XBHPlAAHJM9Dgl Ikjc+ZQX+CfyU/5apP8AkdP/ANU8l+YzMf5P0/d9pd/gn8lP+WqT/kdP/wBU8fzGZf5P0/d9pd/g n8lP+WqT/kdP/wBU8fzGZf5P0/d9pd/gn8lP+WqT/kdP/wBU8fzGZf5P0/d9pd/gn8lP+WqT/kdP /wBU8fzGZf5P0/d9pd/gn8lP+WqT/kdP/wBU8fzGZf5P0/d9paj8k/ktwXndScqDl++n69/914/m My/yfp+77S3/AIJ/JT/lqk/5HT/9U8fzGZf5P0/d9pTbS/yf/LPVLY3Ngs08AYoXFxIPiFCR8SDx yB1eQc2Q7MwHkPtKJl/IvyKsTsLeeqqSP9IbsP8AVwfnMif5Lwd32ltPyK8ilFJt56kA/wC9Lf8A NOP5zIv8l4O77Su/5UT5E/5Z5/8ApJb/AJpx/OZF/kvB3faXf8qJ8if8s8//AEkt/wA04/nMi/yX g7vtKmn5GeRjNIht56KFI/0hu9f8nH85kX+S8Hd9pVP+VE+RP+Wef/pJb/mnH85kX+S8Hd9pZ5ZW os7OC0hQCG2jSKIFiTxRQq1NPAZjE2bc8ChTd0ZvSXYD95HvyP8AvxfbAlWrL/Kv/BH+mKurL/Kv /BH+mKqcplrHUADmK0P9mKpPq03nOO/kbS7e1nsRGOCTErIZODsdwwFOSou/81e2EUqCmuvzDNwX jsrZI6IUhDq67heQZyyNy5cqgLQClGbHZVODUfzJc2yTaVbRLIwNzIsyMYlLMSB8XxECg6fj0OyF K81n8y7OOSRdGt7xQXICMAwHJxGAqyMW24E7dO/g0FTuGbzDc+Xrxrq3W11Vo51t442qK8T6RrVq Hp3xFWp5PA2DBiGBDA0YHrXvXM5wWcWLatJp9uFt7H0oorYiSQSo2/AxuzUAfgUBfiSBuDlJq28X StY6d5nt3T0RaxvI9y8aSeq/puygOAvBg3ErUBQdzvgJioEku1HQ9Xu4ooJDawVcyqFZ2q8kbMRV VYfYg5de48ckJAIlEljepadPp90baZlZwqvyStKOoYfaCnocsBtqkKa0z/jpWn/GaP8A4kMTyWPN keqL5V/S+rNqLXH10X918EeyFPVPHeh365WOKhTYeGzaFjj8isyGSW8QFBzVQrUfwqabfRh9SPQo wReUBConmuDOPV5sg+A0J9IgEV6Ur/DCeJA4UT6fkCv97ehR/q1rRaU+Hx5V9vfB6k+hB6wnlYW9 dKkuGn5KKS040+LkRsP8mn04Y8XVEuHok2Ta3Yq7FXYq9i/Kb/lFn/5iZP8AiKZiZvqcvD9LMLmn 1eWvTg36sqbV0f8Adr8h+rFV2KuxVRjp9am8aJ/HFVbFXYqo3dPSWu37yL/k4uKq2KuxVTm/Y/1x iqpirsVdirsVWTzRQQyTytxiiUvIx7KoqT92KvGNd85aRqGoSXCaDasrH+8lMgkf/Kf0mQVP0/PM uOMgc3FlkBPJGR6fLJbQ3K+X9PMUyo8Z9S5J4yFNyBJsF9QFvpwX5lNeQQ8Fil3IeGkaZFxaVJPV lvECGABnLH1VWlGBrhuupRw30CGuprewt1luNCsCGkaIASXJaqAEmjSk0+LrhG/VB26BCHzDpZ66 BZ/8Fcf9VcPCe9HGO5X0/XtMa/tlGhWaEyoAwa4qKsNxWTAYmuaRIXyRWvazYLr2pRnQrWd0up1a VjPycrI1WPGQCp6mmCMTQ3TKQs7ID9N6fWn+HbSvhW57/wDPTJcJ72PEO5sa1YGlPLtoa9KG57df 92Y8J714h3NDW9PPTy7aH6bn3/4s9seE968Q7mxrVgenl20PyNz/ANVPfHhPevEO5add04Cp8vWg HiWuP+qmPCe9eIdzX+INK/6sFl/wVx/1Vx4T3rxjuaGv6WAB+gbM078rj/qpjwnvXjHc3/iDSv8A qwWX/BXH/VXHhPevGO56h+W13BdeXmlhtI7NPrDr6MJcrUKu/wAbMa/TmNlFFyMRsMmuP955f9Rv 1ZW2Lo/7tfkP1YquxV2KqMf+9M3yT+OKq2KuxVRuv7pf+Mkf/JxcVVsVdiqnN+x/rjFVTFXYq7FX Yqo31pHeWVxaSEiO5ieJyOvF1Kn9eEGkEW8Q1HyD5psrl4hYyXKAkJNAOasOx23H05ljJEuIcUgm dtoEiW6ifQNQkmCRCirIg5L/AHoY+oaiToKKOI8ciZeYZiPkrjRrJHjEnl7VJAPUEjGKYlgRROXG YA+9Cv048R7wnhHcVh0OF/Tp5c1NohQSCRZOWyPUqeaj7TIPs9F96Y8XmEcPkUo1LyprMl0WsNGu 4rcqtEeN6huI5dS+3L3yQmOpYSgegW6f5T8zJf2zvpdyqLKhZjG1AAwJPTCZiuaiBvknmpQ+d4NR 1SCysJ3sZ725nUiEsG9RmXkG8OJqKZAcNC2Z4gTSisv5hrIZV0uRZTwq4tjWkZBRfCgZQ3zGPo71 ufc5ZvzGS2NumnTLHVyKW5qDISWoTU71x9Hetz7lSC8/Ma3Rkh0p41Yk0Fsdq8iaE1PV2P8AsjjU O9bn3LZbn8yJG5NpsopQgLbcQOJU9gNj6aCngBjUO9bn3IbU4fzA1K2a2u9NnaJ3EppAQQyjjsQN q98I4R1RLjPRKP8ACHmn/q1XP/Ipv6ZPjj3sPDl3OHlHzQQCNLuSDuD6bf0x4496+HLud/hDzT/1 arn/AJFN/THjj3r4cu56p+Wmn31h5daC9ge3mNw7CORSrcSq0ND8sxspBOzk4gQGT3Ffq8tOvBqf dlTYuj/u1+Q/Viq7FXYqox1+szeFEp+OKq2KuxVSuq+ktP8Afkf/ACcXFVXFXYqpzfsf64xVUxV2 KpNL5v8AL8fPncPSMO7kQTsAkdA0myH4N9n+yexOGlRMXmDSZb1LKOYtcyEKiiOShJjMtOXHjsi7 77dDuRjSrE8zaC6RSLex+nNzCOTQckClkNaUb4x8J3xpVKbzh5XitnuTqdu0UaNISkisSq0rxAPx dabY0VRR13Rhd/U/rsP1urgW4cFyYxV6KN9sFKl8fnrypI8aLfjnI6xopjlU1kRZErVRQMjghjt9 xw0VtEXHmzy5Aspkv4g0JZZIg37wFSwI4faP2G7Y0rpPNflyNFc6hAwcgIFcEtWm6gdRv1xpVyea PLkkpij1K3eVVDsiyKSFPcgHGlU/8X+WzM0CX8UsqBSyxnnQMSo+zXuN8aVfJ5q0BFicXYkjnXnF JCjyowJYABo1ZeTGNgq9SRQY0rX+KtC4BzcMKz/VQhimEnrfyemU59dulK7dcaVs+atBEDTfW14r bG940YOYAhcuFIB+yMaVuTzT5biBMmp2yAAMS0qgcSFIPXoea/fjSrh5k0EqX+vQhOTojcxRzGod +H8wUMK0xpWn8z+X0uFt21CESugkUcgRxYKQSw+EVEikb9N+mNKstfNflq49YQ6jAVtwxkPNQOMa K7MKndVDDfp92NK03m3y4sRle/iVVeSNqk1DRMFeo6jjUV9t+mNKq3PmTQLVY2uL+GMTKskXJx8S yAspUd6hTjSqUPm7yzMJKajAojcxOJWEfxb7Ufj4HGlaHm7y6bdJxep6TOsQO9QzFwvIAfCD6bbn wxpV0vm3yzE3GTU7dGqQVMgBBBYEEeNUO2NKvTzP5eeX0Y9Rgll5iPhG4duTMEAotf2jjSqL+cPL EcQma/jozBaAMXJPED4AC1P3i70pvjSq48yaCYnl+vRCJJGhaQtRfURBIyhjsaKa7Y0qn/izy1Ri dStwqgMzFwFAYchVjt03/wBvGlbm8z6DHEkslx+4ctxm9OQxj05FjYs4XioDsBUnGlb07zRoGoyr DZ3qSTOXVIiGRyY/tUVwpNKY0qaYFdQHrirsVdiqQH/BXrScfqv1jlL6np09Su3rV4/FTpy7Yd1R Vj/hj60v1H6r9Z+Dj6PDl/dnjTj/AMV1+jFUBN/gL6q/rfUvq3NvU5cePP04+Vff0/T+jj7Y7qoD /lW/oSU+o+l6a+p9n+64pxr348ONPb2x3VHn/B/6UP8AvL+k+T1px9XlX95Sm/2uvvXvXHdVlh/g r9IRfUvqf6Q9ST0+HH1vV4fvP8rlx61x3VqX/BP1qf1Pqv1n1D9Z6cvU+Llz9/tVrjuqnJ/gDhZ+ r9Q4emfqXLhx9Pk1eFduPLljuqC03/Af+I2+pf728hxpy9D1Pq714/scvR58vprvh3QjrX/AXpxf VvqHp8R6XDhTjXalMG6VRv8ABH1e35fUvR9I/VeXCnpfH9ivb7fH/ZU747qtuP8AA/oyfWvqnD1x 6nrU5evw+GvP4uXDp+GO6tt/grivP6rT6q3Hl/yzem3Lr+z6fL6Md1Qj/wDKt6nl9R6rX7P2qLx/ 2VKU747qjY/8Gf6Pw+qU5yfVacacuKc+H+x4dO1Md1ak/wAF/XTy+q/Xfqvanq/VPTP2afFw9OvT HdUu8t/8q6/Rn+430PQ9GT1fV/vfR/a9Tn8XHjSle3TbCbQjJf8AAfrj1vqfr1b7dOVf2q17/PBu lVuP8EeuPrH1L1vSipz4V9Gh9Lr+zx6Y7qhR/wAq59Nv94OHMc+XGnOp61716+9O9Md1VdM/wVwu /q3ocPraetzpT6x6S+nxr/kdPp71x3VB6d/yr79JyfVPS50XpX6vXkePH9jly5U/2VP2sO6o2z/w HzH1T6lz9ROPp8a+pzb06U78+VPeuDdXad/gj1YfqfoevVPSry59E9L7fxUpw4V2pSmO6oG//wCV cfoqb1Pq/wBT5PT0q/a9CPn6NNqejwrx+Hx74d0Kth/yrv6q/wBX+q8ar6/P+99SqU9Tl8fPlx67 1x3SmsP+FvqMfp/VfqPE+l9n0uHNK0r8NOfCvvgVT07/AAj6lj+jvq3Pi/1D0afZrJz48e1fU/4b 3x3VO8CuxV//2Q== xmp.iid:da3a225c-7222-4cc0-8cbf-5380319c04f3 xmp.did:da3a225c-7222-4cc0-8cbf-5380319c04f3 uuid:5D20892493BFDB11914A8590D31508C8 default uuid:61ad1931-3c20-5b48-bce5-d348a3d5679f xmp.did:03a389f0-931c-4f47-98c0-9e2f9ce1448d uuid:5D20892493BFDB11914A8590D31508C8 default saved xmp.iid:44433185-2184-4731-93c4-278700048922 2019-11-26T15:11:19+01:00 Adobe Illustrator CC 2017 (Macintosh) / saved xmp.iid:da3a225c-7222-4cc0-8cbf-5380319c04f3 2020-04-20T17:26:10+02:00 Adobe Illustrator 24.0 (Macintosh) / Print Adobe Illustrator False True 1 35.014958 14.248342 Centimeters Cyan Magenta Yellow Black Groupe de nuances par défaut 0 Blanc CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Noir CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 Rouge CMJN CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 Jaune CMJN CMYK PROCESS 0.000000 0.000000 100.000000 0.000000 Vert CMJN CMYK PROCESS 100.000000 0.000000 100.000000 0.000000 Cyan CMJN CMYK PROCESS 100.000000 0.000000 0.000000 0.000000 Bleu CMJN CMYK PROCESS 100.000000 100.000000 0.000000 0.000000 Magenta CMJN CMYK PROCESS 0.000000 100.000000 0.000000 0.000000 C=15 M=100 J=90 N=10 CMYK PROCESS 15.000000 100.000000 90.000000 10.000000 C=0 M=90 J=85 N=0 CMYK PROCESS 0.000000 90.000000 85.000000 0.000000 C=0 M=80 J=95 N=0 CMYK PROCESS 0.000000 80.000000 95.000000 0.000000 C=0 M=50 J=100 N=0 CMYK PROCESS 0.000000 50.000000 100.000000 0.000000 C=0 M=35 J=85 N=0 CMYK PROCESS 0.000000 35.000000 85.000000 0.000000 C=5 M=0 J=90 N=0 CMYK PROCESS 5.000000 0.000000 90.000000 0.000000 C=20 M=0 J=100 N=0 CMYK PROCESS 20.000000 0.000000 100.000000 0.000000 C=50 M=0 J=100 N=0 CMYK PROCESS 50.000000 0.000000 100.000000 0.000000 C=75 M=0 J=100 N=0 CMYK PROCESS 75.000000 0.000000 100.000000 0.000000 C=85 M=10 J=100 N=10 CMYK PROCESS 85.000000 10.000000 100.000000 10.000000 C=90 M=30 J=95 N=30 CMYK PROCESS 90.000000 30.000000 95.000000 30.000000 C=75 M=0 J=75 N=0 CMYK PROCESS 75.000000 0.000000 75.000000 0.000000 C=80 M=10 J=45 N=0 CMYK PROCESS 80.000000 10.000000 45.000000 0.000000 C=70 M=15 J=0 N=0 CMYK PROCESS 70.000000 15.000000 0.000000 0.000000 C=85 M=50 J=0 N=0 CMYK PROCESS 85.000000 50.000000 0.000000 0.000000 C=100 M=95 J=5 N=0 CMYK PROCESS 100.000000 95.000000 5.000000 0.000000 C=100 M=100 J=25 N=25 CMYK PROCESS 100.000000 100.000000 25.000000 25.000000 C=75 M=100 J=0 N=0 CMYK PROCESS 75.000000 100.000000 0.000000 0.000000 C=50 M=100 J=0 N=0 CMYK PROCESS 50.000000 100.000000 0.000000 0.000000 C=35 M=100 J=35 N=10 CMYK PROCESS 35.000000 100.000000 35.000000 10.000000 C=10 M=100 J=50 N=0 CMYK PROCESS 10.000000 100.000000 50.000000 0.000000 C=0 M=95 J=20 N=0 CMYK PROCESS 0.000000 95.000000 20.000000 0.000000 C=25 M=25 J=40 N=0 CMYK PROCESS 25.000000 25.000000 40.000000 0.000000 C=40 M=45 J=50 N=5 CMYK PROCESS 40.000000 45.000000 50.000000 5.000000 C=50 M=50 J=60 N=25 CMYK PROCESS 50.000000 50.000000 60.000000 25.000000 C=55 M=60 J=65 N=40 CMYK PROCESS 55.000000 60.000000 65.000000 40.000000 C=25 M=40 J=65 N=0 CMYK PROCESS 25.000000 40.000000 65.000000 0.000000 C=30 M=50 J=75 N=10 CMYK PROCESS 30.000000 50.000000 75.000000 10.000000 C=35 M=60 J=80 N=25 CMYK PROCESS 35.000000 60.000000 80.000000 25.000000 C=40 M=65 J=90 N=35 CMYK PROCESS 40.000000 65.000000 90.000000 35.000000 C=40 M=70 J=100 N=50 CMYK PROCESS 40.000000 70.000000 100.000000 50.000000 C=50 M=70 J=80 N=70 CMYK PROCESS 50.000000 70.000000 80.000000 70.000000 Gris 1 C=0 M=0 J=0 N=100 CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 C=0 M=0 J=0 N=90 CMYK PROCESS 0.000000 0.000000 0.000000 89.999400 C=0 M=0 J=0 N=80 CMYK PROCESS 0.000000 0.000000 0.000000 79.998800 C=0 M=0 J=0 N=70 CMYK PROCESS 0.000000 0.000000 0.000000 69.999700 C=0 M=0 J=0 N=60 CMYK PROCESS 0.000000 0.000000 0.000000 59.999100 C=0 M=0 J=0 N=50 CMYK PROCESS 0.000000 0.000000 0.000000 50.000000 C=0 M=0 J=0 N=40 CMYK PROCESS 0.000000 0.000000 0.000000 39.999400 C=0 M=0 J=0 N=30 CMYK PROCESS 0.000000 0.000000 0.000000 29.998800 C=0 M=0 J=0 N=20 CMYK PROCESS 0.000000 0.000000 0.000000 19.999700 C=0 M=0 J=0 N=10 CMYK PROCESS 0.000000 0.000000 0.000000 9.999100 C=0 M=0 J=0 N=5 CMYK PROCESS 0.000000 0.000000 0.000000 4.998800 Couleurs vives 1 C=0 M=100 J=100 N=0 CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 C=0 M=75 J=100 N=0 CMYK PROCESS 0.000000 75.000000 100.000000 0.000000 C=0 M=10 J=95 N=0 CMYK PROCESS 0.000000 10.000000 95.000000 0.000000 C=85 M=10 J=100 N=0 CMYK PROCESS 85.000000 10.000000 100.000000 0.000000 C=100 M=90 J=0 N=0 CMYK PROCESS 100.000000 90.000000 0.000000 0.000000 C=60 M=90 J=0 N=0 CMYK PROCESS 60.000000 90.000000 0.003100 0.003100 Adobe PDF library 15.00

OCS-01: A potential paradigm
shift in DME treatment

One of our most advanced product candidates, OCS-01, is in phase 2 clinical development for DME and also for Pain and inflammation following ocular surgery. The Phase 2 trial in DME (DX-211) with 144 patients was successfully completed providing the first proof-of-concept for a topical drug effect on a chronic retinal disease.

 

OCS-01 has been developed from Oculis’ solubilizing nanoparticle (SNP) technology, a proprietary platform that enables the formulation of drugs as non-invasive topical treatments and enhances their bioavailability in the relevant eye tissues. If approved in DME, it has the potential to provide a new option for patients.

OCS-01: A potential treatment
for Post-cataract Surgery Inflammation

 

Because patients undergoing cataract surgery are usually on several medications daily, adding more eye drops can be challenging. A long-acting topical solution such as OCS-01 has the potential of reducing the frequency of the burden of administration to patients.

OCS-02: THE POTENTIAL OF
topical anti-TNF alpha
therapy for ophthalmic
indications

The compound, named OCS-02, is based on a proprietary single-chain antibody fragment technology specifically designed for topical delivery. Efficacy and safety were evaluated in three clinical trials including two controlled studies under IND. The studies demonstrated a promising profile for treating inflammatory conditions of the anterior segment of the eye including Uveitis and Dry Eye Disease.